ASH, the world's largest professional society concerned with the causes and treatments of blood disorders, regularly issues press releases highlighting clinical and research advances announced at the ASH annual meeting and published in Blood, as well as releases and statements on breaking policy news affecting the field of hematology.
News and Press Releases
Pneumococcal Vaccines Linked with Fewer Severe Infections Among Children with Sickle Cell Disease
Sep. 12, 2023
ASH Names Editors-in-Chief of New Blood Journals
Sep. 8, 2023
Patients with AML Who Received Vitamin C/D Supplements Had Fewer Complications, But No Overall Survival Benefit Seen
Sep. 6, 2023
ASH Announces New ASH-AMFDP Hematology Scholars
Aug. 23, 2023
First-of-its-Kind Study Reveals Predictive Factors for Outcomes of AdvancedStage AL Amyloidosis
Aug. 15, 2023
Obesity and High Weight Linked to Adverse Outcomes in Leukemia Treatment
Jul. 11, 2023
ASH Advocates for Diversity in Medicine
Jun. 30, 2023
ASH Announces the 2023 Honorific Award Recipients
Jun. 28, 2023
Study Uncovers Direct Link Between Blood Group A and a Higher Risk for COVID-19 Infection
Jun. 27, 2023
New Data Informs Treatment of Blood Cancer During Pregnancy
Jun. 1, 2023
Statement on New ASH Clinical Practice Guidelines on Thrombophilia
May 17, 2023
Extreme Poverty a Key Driver for Relapse in Kids With ALL
Apr. 18, 2023
A Promising Outlook: CAR T Cells Improve Patient Quality of Life
Mar. 30, 2023
ASH President Commends Reintroduction of Sickle Cell Disease Medicaid Demonstration Program
Mar. 22, 2023
Quantifying the Life Expectancy Gap for People Living with Sickle Cell Disease
Mar. 16, 2023
Protect Medical Research
Urge your members of Congress to support continued medical research funding.